Lisa Kim

507 total citations
17 papers, 385 citations indexed

About

Lisa Kim is a scholar working on Oncology, Cancer Research and Surgery. According to data from OpenAlex, Lisa Kim has authored 17 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Cancer Research and 5 papers in Surgery. Recurrent topics in Lisa Kim's work include Cancer Genomics and Diagnostics (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Lisa Kim is often cited by papers focused on Cancer Genomics and Diagnostics (6 papers), Chemotherapy-induced cardiotoxicity and mitigation (4 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Lisa Kim collaborates with scholars based in United States, South Korea and Netherlands. Lisa Kim's co-authors include Jung Mook Choi, Eun‐Jung Rhee, Won‐Young Lee, Se Eun Park, Soo Jin Yang, Ki Won Oh, Sung Woo Park, Razelle Kurzrock, Aaron M. Goodman and Brian Calimlim and has published in prestigious journals such as Blood, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Lisa Kim

16 papers receiving 383 citations

Peers

Lisa Kim

SURGE

ONCOL

PRM

Yueli Tian China

Magdalena Białas Poland

Katsuki Miyazaki Japan

Hyeok Shim South Korea

Yuta Takagaki Japan

Ming Kong China

Pixiong Su China

Kyoko Nitta Japan

Yanli Yan China

Yoon Yang Jung South Korea

Yueli Tian China

Lisa Kim

91 ×0.8

SURGE

130 ×1.2

ONCOL

82 ×0.8

104 ×1.1

40 ×0.7

PRM

Citations per year, relative to Lisa Kim Lisa Kim (= 1×) peers Yueli Tian

Countries citing papers authored by Lisa Kim

Since Specialization

Citations

This map shows the geographic impact of Lisa Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Kim more than expected).

Fields of papers citing papers by Lisa Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Kim. The network helps show where Lisa Kim may publish in the future.

Co-authorship network of co-authors of Lisa Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Kim. A scholar is included among the top collaborators of Lisa Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Kim. Lisa Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Louie, Bryan H., Shumei Kato, Ki Hwan Kim, et al.. (2024). Molecular Tumor Board for Unicorns: Outcomes for rare and ultra-rare cancers using an N-of-One personalized treatment strategy. iScience. 27(8). 110465–110465. 2 indexed citations

Khan, Mohammad Irfan, et al.. (2023). Where Have All the Eos Gone? Long Time Passing or in the Heart? ANCA-Associated Crescentic Glomerulonephritis Presenting with Eosinophilic Myocarditis. Journal of the American Society of Nephrology. 34(11S). 280–280.

Guha, Avirup, Amit K. Dey, Raquel E. Reinbolt, et al.. (2022). Hypertensive events after the initiation of contemporary cancer therapies for breast cancer control. Cancer Medicine. 12(1). 297–305. 2 indexed citations

Nishimura, Yoshito, et al.. (2022). Eosinophilic Myocarditis Presenting as Cardiac Tamponade: A Diagnostic Challenge. European Journal of Case Reports in Internal Medicine. 9(9). 3564–3564. 4 indexed citations

Jensen, Taylor J., Aaron M. Goodman, Christopher K. Ellison, et al.. (2021). Genome-wide Sequencing of Cell-free DNA Enables Detection of Copy-number Alterations in Patients with Cancer Where Tissue Biopsy is Not Feasible. Molecular Cancer Therapeutics. 20(11). 2274–2279. 7 indexed citations

Goodman, Aaron M., Lisa Kim, Kerry Fitzgerald, et al.. (2021). Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas. Transplantation and Cellular Therapy. 28(1). 30.e1–30.e7. 18 indexed citations

Kim, Lisa, Brian Fowler, Courtney Campbell, et al.. (2021). Acute cardiotoxicity after initiation of the novel tyrosine kinase inhibitor gilteritinib for acute myeloid leukemia. Cardio-Oncology. 7(1). 36–36. 9 indexed citations

Bonsu, Janice M., Lisa Kim, Patrick Ruz, et al.. (2021). Cardiovascular Safety Communications After US Food and Drug Administration Approval of Contemporary Cancer Therapies. JAMA Oncology. 7(11). 1722–1722. 4 indexed citations

Kim, Lisa, Eméfah Loccoh, Patrick Ruz, et al.. (2020). Contemporary Understandings of Cardiovascular Disease After Cancer Radiotherapy: a Focus on Ischemic Heart Disease. Current Cardiology Reports. 22(11). 151–151. 6 indexed citations

10.

Goodman, Aaron M., Lisa Kim, Kerry Fitzgerald, et al.. (2020). Response to CAR-T Therapy Can be Monitored Using Genome-Wide Sequencing of Cell-Free DNA in Patients with DLBCL. Blood. 136(Supplement 1). 17–17. 2 indexed citations

11.

Jensen, Taylor J., Aaron M. Goodman, Shumei Kato, et al.. (2018). Genome-Wide Sequencing of Cell-Free DNA Identifies Copy-Number Alterations That Can Be Used for Monitoring Response to Immunotherapy in Cancer Patients. Molecular Cancer Therapeutics. 18(2). 448–458. 67 indexed citations

12.

Galanina, Natalie, Rafael Bejar, Michael Y. Choi, et al.. (2018). Comprehensive Genomic Profiling Reveals Diverse but Actionable Molecular Portfolios across Hematologic Malignancies: Implications for Next Generation Clinical Trials. Cancers. 11(1). 11–11. 44 indexed citations

13.

Wang, Anthony, Akshara Richhariya, Shravanthi R. Gandra, et al.. (2016). Systematic Review of Low‐Density Lipoprotein Cholesterol Apheresis for the Treatment of Familial Hypercholesterolemia. Journal of the American Heart Association. 5(7). 73 indexed citations

14.

Chang, Eugene, Lisa Kim, Jung Mook Choi, et al.. (2015). Ezetimibe Stimulates Intestinal Glucagon-Like Peptide 1 Secretion Via the MEK/ERK Pathway Rather Than Dipeptidyl Peptidase 4 Inhibition. Metabolism. 64(5). 633–641. 21 indexed citations

15.

Chang, Eugene, Jung Mook Choi, Lisa Kim, & Cheol‐Young Park. (2015). Bitter Melon Improves Glycemic Control and Inflammation in Adipose Tissue of Obese and Diabetic Rats. The FASEB Journal. 29(S1). 1 indexed citations

16.

Yang, Soo Jin, Jung Mook Choi, Lisa Kim, et al.. (2013). Nicotinamide improves glucose metabolism and affects the hepatic NAD-sirtuin pathway in a rodent model of obesity and type 2 diabetes. The Journal of Nutritional Biochemistry. 25(1). 66–72. 105 indexed citations

17.

Yang, Soo Jin, Jung Mook Choi, Lisa Kim, et al.. (2011). Chronic administration of ezetimibe increases active glucagon-like peptide-1 and improves glycemic control and pancreatic beta cell mass in a rat model of type 2 diabetes. Biochemical and Biophysical Research Communications. 407(1). 153–157. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact